Logotype for Supremex Inc

Supremex (SXP) Q2 2024 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Supremex Inc

Q2 2024 earnings summary

2 Feb, 2026

Executive summary

  • Q2 2024 revenue was CAD 69.3 million, down 3.3% year-over-year, with Envelope revenue up 0.4% to CAD 49.5 million and Packaging revenue down 11.4% to CAD 19.9 million.

  • Adjusted EBITDA was CAD 9 million (13.0% margin), compared to CAD 9.6 million (13.3%) last year.

  • Net earnings were CAD 2 million (CAD 0.08 per share), nearly flat year-over-year.

  • Free cash flow increased to CAD 10.9 million, supporting debt reduction and share repurchases.

  • Announced optimization initiatives in Envelope operations expected to yield annual cost savings over CAD 2 million.

Financial highlights

  • Total revenues were CAD 69.3 million, down 3.3% year-over-year.

  • Envelope revenue rose 0.4% to CAD 49.5 million, with an 8.4%–9.8% volume increase offset by a 7.4%–8.5% drop in average selling price.

  • Packaging and specialty products revenue was CAD 19.9 million, down from CAD 22.4 million last year.

  • Adjusted EBITDA margin for Envelope was 16.2% (down from 19.6%); Packaging margin improved to 13.7% (from 7.4%).

  • Free cash flow for Q2 2024 was CAD 10.9 million, up from CAD 9.8 million in Q2 2023.

Outlook and guidance

  • Demand is gradually returning but recovery is slower than anticipated due to high interest rates and inflation.

  • Optimization initiatives in Envelope and Packaging segments are expected to deliver annual cost savings of CAD 2 million and CAD 1.5 million, respectively.

  • Focus remains on efficiency, productivity, and capturing synergies from acquisitions, with continued pursuit of strategic M&A in Packaging.

  • Backlogs are strong for Q3 and Q4, indicating a positive second half.

  • Expecting to produce more envelopes in 2025 than 2024, with improved utilization and lower fixed costs.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more